RNAi Agent (IMAGE)

Hokkaido University

RNAi Agent

Caption

The newly developed RNAi agent suppressed chronic inflammation in the retinas of diabetic mice. The number of leukocytes (arrows) in the inflamed vasculature was significantly reduced in the RNAi-treated retina (right) comparing to the control experiment (left).

Credit

Kanda A. et al., <i>Molecular Therapy: Nucleic Acid</i>, January 12, 2017

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.